IP Library Granted Patent US 10,512,408
Granted Patent B2
US 10,512,408 · App. 14/830,344 · Granted Dec 24, 2019

System and method for characterizing circulatory blood flow

Inventor: Jan Berkow (Allison Park, PA)
Assignee: Intelomed Inc.
A61B5/0261A61B5/024A61B5/02028A61B5/02116A61B5/4884A61B5/725A61B5/7246A61B5/7278A61B8/06A61B5/1455A61B5/726A61B2562/0247A61B2562/0261
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,512,408
App. No.
14/830,344
Granted
Dec 24, 2019
Kind
B2
Abstract

A computer-implemented method for characterizing circulatory blood volume is disclosed. The method has the steps of acquiring a biological signal that emulates the arterial pulse wave from a sensor. Two derived parameters, circulatory stress, which reflects a harmonic of heart rate, and circulatory blood flow, which reflects the amplitude of the unprocessed biological signal, are extrapolated from the biological signal, and are each compared to a threshold value and assessed to determine an adequacy of circulatory blood volume. In embodiments, the assessment of circulatory blood volume is used to manage a patient's cardiovascular autoregulatory function or the adequacy of transfer of fluids to and from the circulatory system, with the ultimate goal of achieving a circulatory blood volume that adequately supplies the demands of the patient's tissues and organs.

Claims (18)

1. A method for characterizing a circulatory blood flow of a human body, the method comprising:

receiving, by a computing device, a time domain biological signal emulating an arterial pulse wave from a sensor associated with the human body of a patient;

performing frequency analysis of the time domain biological signal to determine at least one of a fundamental frequency and an integer harmonic of a heart rate from the time domain biological signal wherein each of the fundamental frequency and integer harmonic is characterized by a frequency amplitude;

calculating, by the computing device, at least one normalized parameter including calculating a percent difference of at least one of the frequency amplitudes of the at least one of a fundamental frequency and an integer harmonic from the at least one pre-determined parameter baseline;

comparing, by the computing device, the at least one normalized parameter to a predetermined threshold value;

characterizing the circulatory blood flow from the comparison of the at least one normalized parameter to the predetermined threshold value; and

providing an indication reflective of the circulatory blood flow and the changes in circulatory blood volume over contiguous time intervals to a person monitoring the patient's human body for the management of the cardiovascular function of the patient.

2. The method of claim 1 , further comprising calculating, by the computing device, the at least one pre-determined parameter baseline from a variance from a filtered and conditioned time domain biological signal.

3. The method of claim 2 , further comprising dividing, by the computing device, the filtered and conditioned time domain biological signal into a plurality of discrete time windows.

4. The method of claim 2 , wherein the filtered and conditioned time domain biological signal comprises an amplified signal or an inverted signal.

5. The method of claim 1 , further comprising applying, by the computing device, a continuous-time filter to at least a portion of the time domain biological signal.

6. The method of claim 5 , wherein the continuous-time filter comprises one or more of the following:

a Butterworth filter; a Chebyshev filter; a Bessel filter; an elliptical filter; a custom low pass filter; and a filter based on determining a moving average.

7. The method of claim 1 , wherein the sensor comprises one or more of the following:

a transmissive photo-optic sensor; a reflective photo-optic sensor; a pressure transducer; a tonometry device; a strain gauge; an ultrasound device; an electrical impedance device; and a radar device.

8. The method of claim 1 , wherein the predetermined threshold value is a clinically validated value from a specific patient population.

9. The method of claim 1 , wherein the predetermined threshold value is associated with a pre-symptomatic circulatory blood volume inadequacy condition.

10. The method of claim 1 , wherein the predetermined threshold value is associated with a symptomatic circulatory blood volume inadequacy condition.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2026
From: INTELOMED, INC.
To: 219 RBH, LLC
Reel/Frame 074345/0907 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2019
From: BERKOW, JAN
To: INTELOMED, INC.
Reel/Frame 050756/0239 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 19, 2015
From: BERKOW, JAN
To: INTELOMED, INC.
Reel/Frame 036364/0318 →
Continuity (4)
Division 13178966 · Jul 8, 2011
Provisional Application 61362472 · Jul 8, 2010
Provisional Application 61428367 · Dec 30, 2010
Related Publication 20160066799A1 · Mar 10, 2016